Use of oestrogen only hormone replacement therapy associated with increased risk of asthma onset in postmenopausal women

Evidence-Based Medicine

Volumn 15, Issue 6, 2010, Pages 190-191

  Dratva, Julia ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; ASTHMA; BODY MASS; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NOTE; POSTMENOPAUSE; QUESTIONNAIRE; RISK FACTOR;

EID: 78649857887     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm1135     Document Type: Note

References (4)

1. Troisi RJ, Speizer FE, Willett WC, et al. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 1995;152:1183-8.
2. Lange P, Parner J, Prescott E, et al. Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax 2001;56:613-16. (Pubitemid 32706142)
3. Kos-Kudla B, Ostrowska Z, Marek B, et al. Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women. Gynecol Endocrinol 2001;15:304-11.
4. Barr RG, Wertowski CC, Grodstein F et al. Prospective study of postmenopausal homrone use and newly diagnosed asthma and chronic obstructive pulmunary disease. Arch Intern Med 2004; 164: 378-86. (Pubitemid 38240701)